HSCT for Congenital Amegakaryocitic thrombopecytopenia (CAMT) Group Paediatric Diseases Working Party (PDWP) Principal investigator Clémence Aldebert
Monitoring virus-specific T-cell response in allogeneic hematopoietic stem cell transplant recipients Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator Raffaella Greco
Influence of SARS-COV-2 pandemic on handling of allogeneic HPC grafts Diseases Group Infectious Diseases Working Party (IDWP) Cellular Therapy & Immunobiology Working Party (CTIWP) COVID-19 Principal investigator Nina Worrel
Haploidentical stem cell transplantation for congenital bone marrow failure Group Severe Aplastic Anaemia Working Party (SAAWP) Principal investigator Dr. Stefano Giardino
MDS ATG versus Post-Cy in unrelated donors Group Chronic Malignancies Working Party (CMWP) Principal investigator Yves Chalandon, Marie Robin
CLL - Projects about PI, ibrutinib and venetoclax Group Chronic Malignancies Working Party (CMWP) Principal investigator Olivier Tournilhac, Michel van Gelder
Androgens in bone marrow failure disorders Group Severe Aplastic Anaemia Working Party (SAAWP) Type of Stem Cell Treatment Principal investigator Simona Pagliuca, Austin Kulasekararaj
Impact of SARS-CoV-2 vaccination in non-transplanted AA/PNH patients Group Severe Aplastic Anaemia Working Party (SAAWP) COVID-19 Type of Stem Cell Treatment Principal investigator Morag Griffin
Survey Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP) Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Principal investigator Martin Schmidt-Hieber
A prospective outcome study on patients with profound combined immune deficiency (p-CID) Diseases Group Inborn Errors Working Party (IEWP) Type of Stem Cell Treatment Principal investigator Stephan Ehl
Evaluation of killer cell immunoglobulin-like receptor - HLA class I Ligand models for donor selection Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of Stem Cell Treatment Principal investigator Johannes Schetelig
Multi-centre retrospective study to describe the use and outcomes of ECP in combination with new treatment protocols in Acute and Chronic GvHD Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Dr. Olaf Penack